Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

August 9, 2016August 9, 2016

New Test Might Predict Kidney Disease in Pediatric Type 1 Diabetes Patients

News, Type 1 Diabetes News

A team of researchers led by Ioannis Papassotiriou, PhD, of Aghia Sophia Children’s Hospital in Athens, Greece has successfully tested a method for early diagnosis and treatment of pediatric diabetic nephropathy ... Read more

August 2, 2016August 2, 2016

ARA 290 for Pancreatic Islet Cell Transplant Granted Fourth Orphan Designation

News

The US Food and Drug Administration (FDA) has granted the fourth Orphan Drug Designation to Araim Pharmaceuticals’ ARA 290, an innate repair receptor (IRR) activator for increased survival and improved function of pancreatic islets after ... Read more

July 25, 2016July 26, 2016

Type 2 Diabetes Patients Willing to Reach Targets More Than Doctors Think

News

The American Association of Clinical Endocrinologists (AACE) recently reported results from two online surveys that included 1,000 adults with type 2 diabetes (T2D), diagnosed one to five years ago, and 1,004 physicians. ... Read more

July 22, 2016July 22, 2016

Diabetics Hospitalized for Hypoglycemia in England Rises by 39% in Decade

News

Hospital admissions in England for short-term and preventable complications associated with diabetes — specifically, a dangerous drop in blood sugar levels — have increased by 39 percent in the last ... Read more

July 1, 2016July 1, 2016

Type 2 Diabetes: Young Patients Lax with Medicating Show Signs of Depression

News

In a recent study published in the journal Diabetes Care, a team of researchers found that Type 2 diabetes medication adherence is not affected by age, sex, parental education, family ... Read more

June 24, 2016June 24, 2016

Type 2 Diabetes Patients Show Successful Switch to Toujeo in Real-World Setting

News

Sanofi recently released new positive real-world data reports evaluating Toujeo for patients with Type 2 diabetes. The results of the study were presented at the American Diabetes Association 76th Scientific Sessions, June 10 – 14, ... Read more

June 21, 2016June 21, 2016

vTv Therapeutics Presents Positive Data on Pilot Study of Type 2 Diabetes Treatment

insulin resistance, News

vTv Therapeutics presented the findings of a pilot clinical study, now completed, evaluating TTP399, the company’s liver-selective glucokinase activator (GKA), an oral treatment being developed for patients with type 2 diabetes (T2D). Data were presented ... Read more

June 8, 2016June 8, 2016

Ascensia Diabetes Care to Present Data at 76th ADA Scientific Sessions

News

Ascensia Diabetes Care, a global specialist diabetes care company, will attend the upcoming 76th Scientific Sessions of the American Diabetes Association (ADA) June 10-14 in New Orleans. This will be ... Read more

May 18, 2016May 18, 2016

Melatonin Seen to Raise Risk of Type 2 Diabetes in People with a Common Gene Variant

insulin resistance, News, Type 2 Diabetes News

Melatonin, known as the sleep hormone, impairs insulin secretion in people with a common gene variant, according to researchers with Lund University in Sweden. The study, “A Common Variant in TFB1M Is Associated with Reduced ... Read more

May 11, 2016May 11, 2016

Viral Respiratory Infections in Babies Increase Risk for Type 1 Diabetes, Study Shows

News, Type 1 Diabetes News

A team of researchers at the Helmholtz Zentrum München, in Neuherberg, Germany, discovered that viral respiratory infections during the first six months of life increases the risk of type 1 ... Read more